Biogen
BIIB
£93.26
Share price
-3.08%
Change (1 day)
-42.55%
Change (1 year)
Categories
Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
EPS for Biogen (BIIB)
EPS in 2023 (TTM): £15.61
According to Biogen's latest financial reports the company's current EPS (TTM) is £14.44. In 2022 the company made an earnings per share (EPS) of £16.42 an increase over its 2021 EPS that were of £8.16.
EPS history for Biogen from 1996 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | £15.61 | -4.97% |
| 2022 | £16.42 | 101.25% |
| 2021 | £8.16 | -57.43% |
| 2020 | £19.17 | -22.27% |
| 2019 | £24.66 | 45.66% |
| 2018 | £16.93 | 81.39% |
| 2017 | £9.34 | -29.62% |
| 2016 | £13.26 | 10.28% |
| 2015 | £12.03 | 23.65% |
| 2014 | £9.73 | 57.94% |
| 2013 | £6.16 | 35.92% |
| 2012 | £4.53 | 13.53% |
| 2011 | £3.99 | 27.82% |
| 2010 | £3.12 | 18.4% |
| 2009 | £2.64 | 26.22% |
| 2008 | £2.09 | 32.18% |
| 2007 | £1.58 | 215.63% |
| 2006 | £0.50 | 33.33% |
| 2005 | £0.38 | 562.52% |
| 2004 | £0.05669 | -101.48% |
| 2003 | -£3.84 | -606.19% |
| 2002 | £0.76 | -47.28% |
| 2001 | £1.44 | 147.52% |
| 2000 | £0.58 | -311.38% |
| 1999 | -£0.28 | 48.59% |
| 1998 | -£0.19 | 94.52% |
| 1997 | -£0.09520 | 19.67% |
| 1996 | -£0.07955 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | £11.07 | -23.35% | 🇺🇸 USA |
 | £3.44 | -76.22% | 🇺🇸 USA |
 | £2.88 | -80.06% | 🇺🇸 USA |
 | £1.46 | -89.92% | 🇺🇸 USA |
 | £11.02 | -23.70% | 🇺🇸 USA |
 | -£7.65 | -152.97% | 🇺🇸 USA |
 | £2.49 | -82.77% | 🇫🇷 France |
 | -£4.48 | -130.99% | 🇺🇸 USA |
 | -£20.82 | -244.15% | 🇺🇸 USA |
 | £1.14 | -92.12% | 🇳🇱 Netherlands |